report-bg

Plasma Expressor Machine Market Segmentation by Type (Manual, and Automatic); by Application (Plasma Separation, Chemical Research, Blood Testing, Pharmaceutical Research, and Others); and by End-User (Hospital, Institutes & Research Centers, Blood Bank, and Others) – Global Demand Analysis & Opportunity Outlook 2031

Buy Now Report ID: 3991 | Published Date: Feb 02, 2023

Global Plasma Expressor Machine Market Regional Synopsis

On the basis of geographical analysis, the global plasma expressor machine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period on the account of the high prevalence of leukemia and lymphoma in the region. According to the data by the American Cancer Society, in the United States, about 60,650 new cases of leukemia were reported in 2021, out of which, 20,050 cases of acute myeloid leukemia (AML) were reported. The market in the Asia Pacific region is anticipated to gain the largest market share throughout the forecast period growing incidences of blood cancer, along with rising health awareness amongst the people. Moreover, the increasing adoption of advanced medical technology, such as plasma expressor machine, is further estimated to boost the market growth.

Plasma Expressor Machine Market Share Image

The global plasma expressor machine market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook


RN
Plasma Expressor Machine Market Graph
Get more information on this report: Request Free Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


Market Segmentation

Market-Growth-Drivers

Our in-depth analysis of the global plasma expressor machine market includes the following segments:

By Type

  • Manual
  • Automatic

By Application

  • Plasma Separation
  • Chemical Research
  • Blood Testing
  • Pharmaceutical Research
  • Others

By End-User

  • Hospital
  • Institutes & Research Centers
  • Blood Bank
  • Others

Growth Drivers

  • Increasing Prevalence of Blood Cancer
  • Growing Demand for Transfusion of Different Components of Blood
  • Advancement in Medical Technologies

Challenges

  • Limited Availability of Advanced Technology
  • High Initial Price and Maintenance Cost


Global New Cases of Blood Cancer Graph
Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Market

top-features-companies
    • Lonza Group Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Escape Therapeutics, Inc.
    • Regen BioPharma, Inc.
    • ThermoGenesis Holdings, Inc.
    • CSG-BIO Company, Inc. (CellSave)
    • CBR Systems, Inc.
    • Pluristem Inc.
    • Global Cord Blood Corporation
    • ViaCord, LLC
    • Cynata Therapeutics Limited

In-the-news

In The News

  • January 27, 2022: Lonza Group to collaborate with HaemaLogiX Ltd., to manufacture next clinical batch of multiple myeloma drug candidate, KappaMab. 

  • December 08, 2021: ThermoGenesis Holdings, Inc. to join hands with Contract Development Manufacturing Organization (CDMO) to make Cell and Gene therapies available to the maximum patients.


preview-analysis

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.


Author Credits:  Radhika Gupta, Shivam Bhutani


Key Questions Answered in the Report

1) What are the major factors driving the growth of the plasma expressor machine market?

Ans: Increasing prevalence of blood cancer, and other disorders is estimated to boost the market growth

2) What would be the CAGR of plasma expressor machine market over the forecast period?

Ans: The market is anticipated to attain a robust CAGR over the forecast period, i.e., 2022 – 2031.

3) What are the challenges affecting the plasma expressor machine market growth?

Ans: High maintenance cost and limited availability of advanced technology in low-income regions are estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of plasma expressor machine market in future?

Ans: The North America region is anticipated to provide more business opportunities over the forecast period on the back of growing incidences of blood cancer in the region.

5) Who are the major players dominating the plasma expressor machine market?

Ans: The major players in the market are Escape Therapeutics, Inc., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., CSG-BIO Company, Inc. (CellSave), CBR Systems, Inc., Pluristem Inc., ViaCord, LLC, and Cynata Therapeutics Limited.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the plasma expressor machine market?

Ans: The market is segmented by type, application, end-user, and by region.

8) Which segment captures the largest market size in end-user segment in the plasma expressor machine market?

Ans: The hospital segment is anticipated to hold largest market size over the forecast period and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

 Request Free Sample Copy